Monday, Nov. 5, 2012 | CS.01: Clinical Science: Special Reports: Prevention and Treatment of Ischemic Heart Disease: Novel Approaches | 
Stefan Mark Nidorf
Heart Care WA
Perth, Australia | Low Dose Colchicine for Secondary Prevention of Cardiovascular Disease [LoDoCo]: A Randomized Controlled Trial
Presenter Slides | Presentation Audio | Discussant Audio | 
Wei Jiang
Duke University Medical Center
Durham, NC | Results of the Responses of Myocardial Ischemia to Escitalopram Treatment Trial
Presentation Slides | Presentation Audio | Discussant Audio | 
L Kristin Newby
Duke University Medical Center
Durham, NC | Safety and Efficacy of Losmapimod in Non-ST-Segment Elevation Acute Myocardial Infarction: Results of the SOLSTICE Phase 2 Randomized Trial
Presentation Slides | Presentation Audio | Discussant Audio | 
Vasilios Papademetriou
VA Med Ctr, Washington, DC | EnligHTN™ I, First-in-man Multi-center Study of a Novel Multi-electrode Renal Denervation Catheter in Patients with Drug-Resistant Hypertension
Presentation Audio | Discussant Audio |
|
Back to Top
|
| CS.02: Clinical Science: Special Reports: New Insights into Management of Common Cardiovascular Disorders | David G Jones
Royal Brompton & Harefield, Imperial Coll, London, United Kingdom | A Randomised Trial to Assess Catheter Ablation versus Rate Control in the Management of Persistent Atrial Fibrillation in Chronic Heart Failure | Xue Zhao
Shanghai Changzheng Hosp,Second Military Medical Univ, Shanghai, China | Pulmonary Antrum Radial-linear Ablation of Paroxysmal Atrial Fibrillation: First-in-human Multicenter Clinical Outcome | Hung-Fat Tse
The Univ of Hong King, Hong Kong, Hong Kong | "Prospective Randomized Study to Assess the Efficacy of Site and Rate of Atrial Pacing on Long-term Progression of Atrial Fibrillation in Sick Sinus Syndrome- Septal Pacing for Atrial Fibrillation Suppression Evaluation [SAFE] Study" | Marc Semigran
Massachusetts General Hosp Heart Ctr, Boston, MA | Left Ventricular Systolic Dysfunction Associated With Pulmonary Hypertension Riociguat Trial (LEPHT) | Mads J Andersen
Rigshospitalet, København Ø, Denmark | "Sildenafil and Diastolic Dysfunction After Acute Myocardial Infarction in Patients with Preserved Ejection Fraction - A Prospective, Double Blinded Placebo-controlled Randomized Trial (SIDAMI)" |
|
Back to Top
|
Tuesday, Nov. 6, 2012 | CS.03: Clinical Science: Special Reports: Emerging Therapeutics for Diabetes and Dyslipidemia | 
Julio Rosenstock
Dallas Diabetes and Endocrine Ctr., Dallas, TX | Impact of LX4211, a Dual Inhibitor of Sodium Glucose Transporter 1 and 2 on Cardiovascular Risk Factors in Type 2 Diabetes | 
Robert P Guigliano
Brigham and Womens Hosp, Boston, MA | LAPLACE-TIMI 57 Primary Results | 
Michael J. Koren
Jacksonville Ctr for Clinical Res, Jacksonville, FL | Efficacy and Safety of a Fully Human Monoclonal Antibody Against PCSK9 as Monotherapy for Hypercholesterolemia: Results from the MENDEL Study, a Global Phase 2 Trial of AMG 145 | 
Nihar R Desai
TIMI Study Group, Div of Cardiovascular Med, Brigham and Women's Hosp, Boston, MA | AMG 145, a Fully Human Monoclonal Antibody Against Proprotein Convertase Subtilisin Kexin type 9 (PCSK9), Facilitates Achievement of NCEP LDL-Cholesterol Goals in High-Risk Patients |
|
Back to Top
|
Wednesday, Nov. 7, 2012 | CS.04: Clinical Science: Special Reports: Valvular Heart Disease, PAD, Atrial Fibrillation: International Perspectives | K.M. John Chan
Imperial Coll London, London, United Kingdom | Mitral Valve Annuloplasty Plus CABG versus CABG Only in Moderate Functional Ischemic Mitral Regurgitation: Final Results of the Randomized Ischemic Mitral Evaluation (RIME) Trial
| Masato Nakamura
Toho Univ, Ohashi medical Ctr, Tokyo, Japan | EndOVascular Treatment for Infra-inguinal Vessel, in Patients With Critical Limb Sichemia (olive) Registry in Japan | Mohammad Zubaid
Faculty of Med, Kuwait Univ, Kuwait City, Kuwait | Management and One Year Outcome of Atrial Fibrillation in Middle Eastern Cohort Enrolled in the Observational Gulf Survey of Atrial Fibrillation Events (Gulf SAFE)
| Steven Swiryn
Northwestern Univ, Chicago, IL | Clinical Implications of Device-Detected Atrial Tachyarrhythmias: Results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes in the Cardiac Rhythm Management Device Population (RATE)
Presentation Slides
| Ajay K Kakkar
Thrombosis Res Inst, London, United Kingdom | Antithrombotic Treatments and Associated Outcomes in Patients with Atrial Fibrillation: The Global Anticoagulant Registry in the FIELD (GARFIELD)
| Stuart J Connolly
McMaster Univ, Hamilton, ON, Canada | Randomized Comparison of the Effects of Two Doses of Dabigatran Etexilate on Clinical Outcomes Over 4.3 Years: Results of the Rely-able Double-blind Randomized Trial
| | | |
|
Back to Top
|
